Target intelligence / Profile preview

Fascin actin-bundling protein 3 (FSCN3)

Target
FSCN3
Molecular classification
Actin-bundling protein, Cytoskeletal protein, Other
01

Overview

Fascin actin-bundling protein 3 (FSCN3) is a member of the fascin family of small, globular actin-bundling proteins with four β-trefoil domains, each containing distinct actin-binding sites[2][3][4]. Fascin proteins organize actin filaments into tightly packed, well-ordered bundles that support membrane protrusions (filopodia, microspikes, invadopodia) involved in cell motility, migration, and invasion[1][2][3]. Fascin-3 has tissue-specific expression, primarily in the testis, where it is thought to play a role in spermatogenesis and the formation of cytoskeletal structures essential for sperm development. Dysregulation of fascin proteins (especially fascin-1) is implicated in cancer metastasis and is being investigated as a therapeutic target; inhibitors such as G2 disrupt actin bundling by interfering with fascin’s actin-binding sites[3]. Fascin proteins, including fascin-3, bind actin filaments through two major actin-binding sites and may dimerize for bundling activity[2][3][4].\n\nIf you need more information specific to fascin-3's testicular roles or related disease associations, further literature review on FSCN3 is recommended. If your context was fascin-1 (the most well-studied isoform in cancer), please clarify, as much research and drug targeting focuses on fascin-1[2][3].

Other names
Fascin-3Testis fascinFSCN3
02

Mechanism of action

Allosteric inhibition of actin bundling by fascin inhibitors (e.g., G2 disrupts F-actin cross-linking by binding fascin and blocking actin-binding interfaces[3].)

03

Biological functions

Actin filament bundlingCytoskeletal organizationPromotion of membrane protrusions (e.g., filopodia)Cell motilityOther
04

Disease associations

Cancer
05

Safety considerations

Cytoskeletal disruptionOff-target effects
06

Interacting drugs

G2
07

Biomarkers

Overexpression in tissues

Beyond the preview

Go deeper on Fascin actin-bundling protein 3 (FSCN3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fascin actin-bundling protein 3 (FSCN3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call